Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 801 participants.
Also called NCT01294462
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 801 participants
- Sponsor
- Registry
-
NCT01294462
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan, South Korea, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01294462. Randomized; quadruple masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2012-07 (actual). Results posted on 2014-05-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
- Condition
- Acute Coronary Syndrome
- Condition
- Percutaneous Coronary Intervention
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Acetylsalicylic acid ASA
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct01294462- Content hash
93ffdf6b97c44d674735cabf3a1f59f033ecf927b4e41fbaca6c90c582f3fae6